PharmaCyte Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 18.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.73%	K2 & Associates Investment Management Inc.	209,266	US$366.2k	-36.1%	0.19%
2.51%	The Vanguard Group, Inc.	192,387	US$336.7k	0%	no data
2.47%	Iroquois Capital Management, LLC	189,350	US$331.4k	0%	14.09%
2.19%	Geode Capital Management, LLC	168,200	US$294.4k	-4.76%	no data
1.83%	Intracoastal Capital LLC	140,265	US$245.5k	0%	no data
1.08%	Equitec Group, LLC, Asset Management Arm	82,727	US$144.8k	0%	1.32%
1.08%	Daniel Asher	82,727	US$144.8k	0%	no data
0.65%	Joshua Silverman	50,000	US$87.5k	0%	no data
0.65%	Jonathan Schechter	50,000	US$87.5k	0%	no data
0.65%	Jns Holdings Group Llc	50,000	US$87.5k	0%	no data
0.65%	Renaissance Technologies LLC	49,700	US$87.0k	2.47%	no data
0.46%	Susquehanna International Group, LLP, Asset Management Arm	35,228	US$61.6k	-35.8%	no data
0.36%	Dimensional Fund Advisors LP	27,601	US$48.3k	7.83%	no data
0.34%	Schonfeld Strategic Advisors LLC	25,900	US$45.3k	9.28%	no data
0.25%	Northern Trust Global Investments	19,208	US$33.6k	0%	no data
0.14%	Carlos Trujillo	10,400	US$18.2k	0%	no data
0.11%	UBS Asset Management AG	8,354	US$14.6k	-69.7%	no data
0.047%	Kenneth Waggoner	3,598	US$6.3k	0%	no data
0.037%	Tower Research Capital Europe Limited	2,860	US$5.0k	-61.3%	no data
0.037%	Acadian Asset Management LLC	2,851	US$5.0k	0%	no data
0.036%	Michael Abecassis	2,802	US$4.9k	0%	no data
0.026%	Strategic Investment Solutions, Inc.	2,000	US$3.5k	0%	no data
0.021%	Lord, Abbett & Co. LLC	1,618	US$2.8k	0%	no data
0.02%	Securities America Advisors, Inc.	1,545	US$2.7k	0%	no data
0.01%	Aspire Private Capital, LLC	800	US$1.4k	0%	no data